Evidence map›Paper›PMID 34327567›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Empirical treatment with doxycycline of fever of intermediate duration.

Emilio Guirao-Arrabal, Leopoldo Muñoz-Medina, Francisco Anguita-Santos, David Vinuesa-García, José Hernández-Quero

Open access · greenAbstract readLetter
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. A molecular toolbox for fast and convenient diagnosis of emerging and reemerging bacterial pathogens causing fever of intermediate duration.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Emilio Guirao-ArrabalInfectious Disease Unit, Hospital Universitario San Cecilio, Avenida de la Investigación s/n. 18014, Granada, Spain. emilio.guirao@gmail.com.ORCID 0000-0003-4877-6484
Leopoldo Muñoz-MedinaInfectious Disease Unit, Hospital Universitario San Cecilio, Avenida de la Investigación s/n. 18014, Granada, Spain.
Francisco Anguita-SantosInfectious Disease Unit, Hospital Universitario San Cecilio, Avenida de la Investigación s/n. 18014, Granada, Spain.
David Vinuesa-GarcíaInfectious Disease Unit, Hospital Universitario San Cecilio, Avenida de la Investigación s/n. 18014, Granada, Spain.
José Hernández-QueroInfectious Disease Unit, Hospital Universitario San Cecilio, Avenida de la Investigación s/n. 18014, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsCommunicable DiseasesDoxycyclineFeverHumansAnti-Bacterial AgentsDoxycycline

Identifiers

PMID34327567
PMCPMC8321886
OpenAlexW3186632667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.